No evidence for shared etiology in two demyelinative disorders, MS and PLOSL

Journal of Neuroimmunology

Volumn 206, Issue 1-2, 2009, Pages 86-90

  Sulonen, Anna Maija ^a   Kallio, Suvi P ^a   Ellonen, Pekka ^a,i   Suvela, Minna ^a   Elovaara, Irina ^b,c   Koivisto, Keijo ^d   Pirttilä, Tuula ^e   Reunanen, Mauri ^f   Tienari, Pentti J ^g   Palotie, Aarno ^a,h,i   Peltonen, Leena ^a,h,i   Saarela, Janna ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

ⁱ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Association; DAP12; MS; PLOSL; TREM2

Indexed keywords

KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MEMBRANE RECEPTOR;

ARTICLE; BONE DYSPLASIA; CONTROLLED STUDY; DEMYELINATING DISEASE; FINLAND; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUCOENCEPHALOPATHY; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BRAIN DISEASES; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME MAPPING; DEMYELINATING DISEASES; DNA-DIRECTED DNA POLYMERASE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MULTIPLE SCLEROSIS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; SEQUENCE ANALYSIS;

EID: 58149472884     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.10.005     Document Type: Article

References (31)

1. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
2. Cottingham Jr. R.W., Idury R.M., and Schäffer A.A. Faster sequential genetic linkage computations. Am. J. Hum. Genet. 53 (1993) 252-263
3. Dyment D.A., Ebers G.C., and Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol. 3 (2004) 104-110
4. Ebers G.C., Sadovnick A.D., and Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Nature 377 (1995) 150-151
5. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R.B., Hader W., Paty D.W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J.E., Murray T.J., Pryse-Phillips W., Nelson R., Freedman M., Brunet D., Bouchard J.P., Hinds D., and Risch N. A full genome search in multiple sclerosis. Nat. Genet. 13 (1996) 472-476
6. Fenoglio C., Galimberti D., Piccio L., Scalabrini D., Panina P., Buonsanti C., Venturelli E., Lovati C., Forloni G., Mariani C., Bresolin N., and Scarpini E. Absence of TREM2 polymorphisms in patients with Alzheimer's disease and frontotemporal lobar degeneration. Neurosci. Lett. 411 (2007) 133-137
7. Haghighi S., Andersen O., Nilsson S., Rydberg L., and Wahlström J. A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy. Mult. Scler. 12 (2006) 723-730
8. Haines J.L., Ter-Minassian M., Bazyk A., Gusella J.F., Kim D.J., Terwedow H., Pericak-Vance M.A., Rimmler J.B., Haynes C.S., Roses A.D., Lee A., Shaner B., Menold M., Seboun E., Fitoussi R.-P., Gartioux C., Reyes C., Ribierre F., Gyapay G., Weissenbach J., Hauser S.L., Goodkin D.E., Lincoln R., Usuku K., Garcia-Merino A., Gatto N., Young S., and Oksenberg J.R. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat. Genet. 13 (1996) 469-471
9. Haines J.L., Bradford Y., Garcia M.E., Reed A.D., Neumeister E., Pericak-Vance M.A., Rimmler J.B., Menold M.M., Martin E.R., Oksenberg J.R., Barcellos L.F., Lincoln R., Hauser S.L., and Multiple Sclerosis Genetics Group. Multiple susceptibility loci for multiple sclerosis. Hum. Mol. Genet. 11 (2002) 2251-2256
10. Hakola P. Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (membranous lipodystrophy): a neuropsychiatric follow-up study. Monogr. Psych. Fenn. 17 (1990) 1-114
11. International Multiple Sclerosis Genetics Consortium, Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., and Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 (2007) 851-862
12. Kaifu T., Nakahara J., Inui M., Mishima K., Momiyama T., Kaji M., et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111 (2003) 323-332
13. Kiialainen A., Hovanes K., Paloneva J., Kopra O., and Peltonen L. Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiol. Dis. 18 (2005) 314-322
14. Klesney-Tait J., Turnbull I.R., and Colonna M. The TREM receptor family and signal integration. Nat. Immunol. 7 (2006) 1266-1273
15. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikström J., Palo J., Stein L.D., Hudson T.J., Lander E.S., and Peltonen L. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61 (1997) 1379-1387
16. Lathrop G.M., and Lalouel J.M. Easy calculations of LOD scores and genetic risks on small computers. Am. J. Hum. Genet. 36 (1984) 460-465
17. Nataf S., Anginot A., Vuaillat C., Malaval L., Fodil N., Chereul E., Langlois J.B., Dumontel C., Cavillon G., Confavreux C., Mazzorana M., Vico L., Belin M.F., Vivier E., Tomasello E., and Jurdic P. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am. J. Pathol. 166 (2005) 275-286
18. Oksenberg J.R., and Barcellos L.F. Multiple sclerosis genetics: leaving no stone unturned. Genes Immun. 6 (2005) 375-387
19. Paloneva J., Kestilä M., Wu J., Salminen A., Böhling T., Ruotsalainen V., Hakola P., Bakker A.B., Phillips J.H., Pekkarinen P., Lanier L.L., Timonen T., and Peltonen L. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25 (2000) 357-361
20. Paloneva J., Autti T., Raininko R., Partanen J., Salonen O., Puranen M., Hakola P., and Haltia M. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology 56 (2001) 1552-1558
21. Paloneva J., Manninen T., Christman G., Hovanes K., Mandelin J., Adolfsson R., Bianchin M., Bird T., Miranda R., Salmaggi A., Tranebjaerg L., Konttinen Y., and Peltonen L. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71 (2002) 656-662
22. Reunanen K., Finnilä S., Laaksonen M., Sumelahti M.L., Wikström J., Pastinen T., Kuokkanen S., Saarela J., Uimari P., Ruutiainen J., Ilonen J., Peltonen L., and Tienari P.J. Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study. J. Neuroimmunol. 126 (2002) 134-142
23. Roumier A., Béchade C., Poncer J.C., Smalla K.H., Tomasello E., Vivier E., Gundelfinger E.D., Triller A., and Bessis A. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J. Neurosci. 24 (2004) 11421-11428
24. Sadovnick A.D., Armstrong H., Rice G.P., Bulman D., Hashimoto L., Paty D.W., Hashimoto S.A., Warren S., Hader W., and Murray T.J. A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 33 (1993) 281-285
25. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., and Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13 (1996) 464-468
26. Silander K., Axelsson T., Widen E., Dahlgren A., Palotie A., and Syvänen A.C. Analysis of genetic variation in the GenomEUtwin project. Twin Res. 6 (2003) 391-398
27. Sumelahti M.L., Tienari P.J., Wikstrom J., Palo J., and Hakama M. Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993. Neuroepidemiology 19 (2000) 67-75
28. Sumelahti M.L., Tienari P.J., Wikstrom J., Palo J., and Hakama M. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol. Scand. 103 (2001) 153-158
29. Takahashi K., Rochford C.D., and Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201 (2005) 647-657
30. Takahashi K., Prinz M., Stagi M., Chechneva O., and Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 4 (2007) e124
31. Wikstrom J., and Palo J. Studies on the clustering of multiple sclerosis in Finland I: Comparison between the domiciles and places of birth in selected subpopulations. Acta Neurol. Scand. 51 (1975) 85-98